View of HETEROGENEITY IN CANCER RISK ASSOCIATED WITH ANTIHYPERTENSIVE DRUG USE: A META-ANALYSIS OF LOSARTAN AND AMLODIPINE

Return to Article Details HETEROGENEITY IN CANCER RISK ASSOCIATED WITH ANTIHYPERTENSIVE DRUG USE: A META-ANALYSIS OF LOSARTAN AND AMLODIPINE Download Download PDF